Home›Trial›NCT06208878
🔬NCT06208878ENROLLING BY INVITATION

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Study Summary

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

Conditions
Hematologic MalignancySolid Malignancy
Interventions / Drugs
Non Interventional
View on ClinicalTrials.gov ↗
Sponsor
CRSP
CRISPR Therapeutics
Gene Editing
D43/100
Study Details
Enrollment70 participants
Primary Completion—
Lead SponsorCRISPR Therapeutics AG
Data Retrieved2026-04-11 04:10:52.768024+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.